Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
According to Manishi Raychaudhuri of BNP Paribas Securities, IT may offer some tactical trading opportunities while one can stay away from pharma space.
Shahina Mukadam, Independent Market Expert is of the view that one may buy Sun Pharmaceutical Industries on dips.
Sun Pharma, among others, are being tracked by analysts on Tuesday.
Ashwani Gujral of ashwanigujral.com recommends buying Bajaj Finserv, Tata Steel, Sun Pharmaceutical Industries, Heritage Foods and Jaiprakash Associates.
Motilal Oswal expects Axis Bank to report 1.3-1.4 percent return on assets (ROA) and 16 percent return on equity (RoE).
Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter
VK Sharma, Head - PCG and Capital Market Strategy at HDFC securities recommends buying Lupin, Sun Pharmaceutical Industries, ICICI Bank and Container Corporation of India.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy HDFC and Petronet LNG and sell Berger Paints while one can hold PNB Housing Finance.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Tata Global Beverage and Hindustan Unilever and can sell Lupin, Sun Pharmaceutical Industries and Glenmark Pharma.
Ashwani Gujral of ashwanigujral.com recommends selling Biocon, Ceat and Adani Enterprises.
Mitessh Thakkar of mitesshthakkar.com advises buying Jubilant Foodworks and HDFC.
In an interview to CNBC-TV18, Amey Chalke of HDFC Securities spoke about the latest happenings in Dr Reddy's Laboratories and the overall pharma sector.
SBI, Cipla and TVS Motor, among others, are being tracked by investors on Monday.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Edelweiss Financial Services and Titan Company and can sell Sun Pharmaceutical Industries, Granules India and Divis Laboratories.
In an interview to CNBC-TV18, Surajit Pal, Pharma Analyst at Prabhudas Lilladher shared his views and readings on the latest happenings in pharmaceutical space especially on Sun Pharmaceutical Industries and Aurobindo Pharma.
Sun Pharma is n focus after Taro, its US arm, reports a 30 percent decline in net sales. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on the same as well as on some other pharma stocks.
Sudarshan Sukhani of s2analytics.com suggests selling Godrej Consumer, UPL and Sun TV Network and advises buying IGL and Bharat Forge.
In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Mahindra and Mahindra and Coal India and buy Manappuram Finance while can hold Tech Mahindra.
According to Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9920 and the resistance is at 10036-10069. On the other hand, Bank Nifty has support at 24650 and resistance at 25550.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Siemens and sell Hindalco Industries and Sun Pharmaceutical Industries.
Ashwani Gujral of ashwanigujral.com suggests buying ICICI Prudential, Reliance Capital and Mahanagar Gas.
Ashwani Gujral of ashwanigujral.com suggests buying Bajaj Finance, Sun Pharma Advanced Research, Adani Power, Bhushan Steel and State Trading Corporation of India.
According to Prakash Gaba of prakashgaba.com, support for Nifty is placed at 9920 and resistance at 10036-69 while Bank Nifty has support at 24500 and resistance at 24775.